HCWB is trading at $3.26 (+26.53%) today after announcing a $4.0 million private placement and releasing positive preclinical data for its T-cell engager program.
- The stock is extending a sharp multi-day rally, gaining significant momentum over the last three sessions amid elevated volatility.
- The $4.0 million private placement provides the company with fresh capital to support its ongoing development pipeline and clinical milestones.